A detailed history of Natixis Advisors, L.P. transactions in Johnson & Johnson stock. As of the latest transaction made, Natixis Advisors, L.P. holds 1,556,013 shares of JNJ stock, worth $238 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
1,556,013
Previous 1,301,152 19.59%
Holding current value
$238 Million
Previous $190 Million 32.6%
% of portfolio
0.49%
Previous 0.41%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$145.48 - $167.38 $37.1 Million - $42.7 Million
254,861 Added 19.59%
1,556,013 $252 Million
Q2 2024

Aug 01, 2024

SELL
$144.38 - $157.78 $26.9 Million - $29.4 Million
-186,044 Reduced 12.51%
1,301,152 $190 Million
Q1 2024

Apr 25, 2024

BUY
$155.22 - $162.74 $6.49 Million - $6.8 Million
41,806 Added 2.89%
1,487,196 $235 Million
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $12.2 Million - $13.3 Million
-83,536 Reduced 5.46%
1,445,390 $227 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $16.1 Million - $18.1 Million
-103,538 Reduced 6.34%
1,528,926 $238 Million
Q2 2023

Aug 15, 2023

BUY
$154.35 - $166.11 $61.1 Million - $65.8 Million
396,111 Added 32.04%
1,632,464 $270 Million
Q1 2023

May 11, 2023

SELL
$151.05 - $180.26 $25.5 Million - $30.5 Million
-168,967 Reduced 12.02%
1,236,353 $192 Million
Q4 2022

Jan 27, 2023

BUY
$160.2 - $179.79 $15.8 Million - $17.7 Million
98,436 Added 7.53%
1,405,320 $248 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $11.7 Million - $13 Million
-72,622 Reduced 5.26%
1,306,884 $213 Million
Q2 2022

Aug 12, 2022

BUY
$168.19 - $186.01 $3.07 Million - $3.39 Million
18,244 Added 1.34%
1,379,506 $245 Million
Q1 2022

May 12, 2022

BUY
$158.14 - $179.59 $65.3 Million - $74.1 Million
412,785 Added 43.52%
1,361,262 $241 Million
Q4 2021

Feb 08, 2022

BUY
$155.93 - $173.01 $12.1 Million - $13.4 Million
77,502 Added 8.9%
948,477 $162 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $4.53 Million - $5.04 Million
28,078 Added 3.33%
870,975 $141 Million
Q2 2021

Aug 12, 2021

BUY
$159.48 - $171.07 $11.7 Million - $12.6 Million
73,452 Added 9.55%
842,897 $139 Million
Q1 2021

May 05, 2021

BUY
$153.07 - $170.48 $3.02 Million - $3.37 Million
19,752 Added 2.63%
769,445 $126 Million
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $1.11 Million - $1.28 Million
8,112 Added 1.09%
749,693 $118 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $1.53 Million - $1.67 Million
10,883 Added 1.49%
741,581 $110 Million
Q2 2020

Aug 11, 2020

SELL
$128.81 - $155.51 $17.9 Million - $21.6 Million
-139,185 Reduced 16.0%
730,698 $103 Million
Q1 2020

Apr 27, 2020

BUY
$111.14 - $153.99 $13.6 Million - $18.9 Million
122,794 Added 16.44%
869,883 $114 Million
Q4 2019

Feb 10, 2020

BUY
$127.5 - $146.44 $27.9 Million - $32.1 Million
219,062 Added 41.49%
747,089 $109 Million
Q3 2019

Nov 12, 2019

SELL
$126.95 - $142.14 $3.08 Million - $3.45 Million
-24,277 Reduced 4.4%
528,027 $68.3 Million
Q2 2019

Aug 12, 2019

BUY
$131.15 - $144.24 $4.97 Million - $5.47 Million
37,899 Added 7.37%
552,304 $76.9 Million
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $6.13 Million - $6.82 Million
48,797 Added 10.48%
514,405 $71.9 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $1.43 Million - $1.72 Million
-11,666 Reduced 2.44%
465,608 $60.1 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $8.44 Million - $9.91 Million
69,389 Added 17.01%
477,274 $65.9 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $430,198 - $474,731
-3,603 Reduced 0.88%
407,885 $0
Q1 2018

May 10, 2018

BUY
$125.1 - $148.14 $1.36 Million - $1.62 Million
10,909 Added 2.72%
411,488 $52.7 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $2.53 Million - $2.77 Million
19,292 Added 5.06%
400,579 $56 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $49.4 Million - $51.6 Million
381,287
381,287 $49.6 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $400B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.